Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits

Journal of Thoracic and Cardiovascular Surgery

Volumn 123, Issue 4, 2002, Pages 742-755

  Aldea, Gabriel S ^b   Soltow, Louise O ^b   Chandler, Wayne L ^b   Triggs, Christopher M ^a   Vocelka, Craig R ^b   Crockett, Gregory I ^b   Shin, Yong T ^b   Curtis, William E ^b   Verrier, Edward D ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA THROMBOGLOBULIN; HEPARIN; NEURON SPECIFIC ENOLASE; THROMBIN;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; DEVICE; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LEUKOCYTE ACTIVATION; MALE; PRIORITY JOURNAL; SUCTION; SURGICAL TECHNIQUE; THROMBOCYTE ACTIVATION; THROMBOGENESIS;

EID: 0036090385     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2002.120347     Document Type: Article

References (36)

1. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations
2. Complement activation during cardiopulmonary bypass: Effects of immobilized heparin
3. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass
4. High and low heparin dose with heparin-coated cardiopulmonary bypass circuits: Activation of complement and granulocytes
5. Heparin-coated cardiopulmonary bypass equipment. II: Mechanisms for reduced complement activation in vivo
6. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass
7. Heparin coated bypass circuits (Carmeda) suppresses the release of tissue plasminogen activator during coronary artery bypass graft surgery
8. Surface-bound heparin - Panacea or peril?
9. Heparin-bonded cardiopulmonary bypass circuits and a reduced anticoagulation protocol in patients undergoing primary CABG: A prospective randomized study
10. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits
11. Decreased blood loss after cardiopulmonary bypass using heparin-coated circuit and 50% reduction of heparin dose
12. Heparin coating of an extracorporeal circuit partly improves hemostasis after cardiopulmonary bypass
13. Enhanced blood conservation and improved clinical outcome after valve surgery using heparin-bonded cardiopulmonary bypass circuits
14. Heparin-bonded circuits improve clinical outcomes in patients undergoing CABG: A new "gold" standard?
15. Beneficial effects of Durafio II heparin-coated circuits on postperfusion lung dysfunction
16. Heparin-coated circuits for high-risk patients: A multicenter prospective randomized trial
17. A prospective randomized trial of Duraflo II heparincoated circuits in cardiac reoperations
18. Cardiotomy suction: A major source of brain lipid emboli during cardiopulmonary bypass
19. Influence of different autotransfusion devices on the quality of salvaged blood
20. Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass
21. The effect of cardiotomy suction on brain injury markers and S100β after cardiopulmonary bypass
22. Neuron-specific enolase increase in plasma during and immediately after extracorporeal circulation
23. Influence of two blood conservation techniques (cardiotomy reservoir versus cell saver) on biocompatibility of heparin coated cardiopulmonary bypass during coronary revascularization surgery
24. Atherosclerosis of the ascending aorta: Prevalence and role as an independent predictor of cerebrovascular events in cardiac patients
25. Significance of serum S1000 release after coronary artery bypass grafting
26. Cerebral emboli and serum S100β during cardiac operations
27. Neuropsychologic dysfunction after cardiac surgery: What is the problem?
28. Neuropsychologic change after cardiac surgery: A clinical review
29. Defining neuropsychological dysfunction after coronary artery bypass grafting
30. Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemia
31. Neuron-specific enolase
32. Cerebral complications after cardiac surgery assessed by S-100 and NSE levels in blood
33. Serum S-100 protein concentration after cardiac surgery: A randomized trial of arterial line filtration
34. S-100β after coronary artery surgery: Release pattern, source of contamination and relation to neuropsychological outcome
35. Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources
36. S 100B as a predictor of size and outcome of stroke after cardiac surgery